Evidence map›Paper›PMID 28845756›Full record

ArticleCritical reviews in immunology2016

The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Lee Ann Garrett-Sinha, Alyssa Kearly, Anne B Satterthwaite

Open access · greenAbstract read
In one paragraph

Article in Critical reviews in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Non-Coding Variant inFrontiers in lupus · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lee Ann Garrett-SinhaDepartment of Biochemistry, State University of New York at Buffalo, Buffalo, NY 14203.
Alyssa KearlyDepartment of Biochemistry, State University of New York at Buffalo, Buffalo, NY 14203.
Anne B SatterthwaiteDepartment of Internal Medicine, Rheumatic Diseases Division; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
University at Buffalo, State University of New York · USThe University of Texas Southwestern Medical Center · US

Funding

Regulation and Consequences of Ets1 Downregulation in B CellsR01AI122720 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARRETT-SINHA, LEE ANN, SATTERTHWAITE, ANNE B · 2016 to 2020
$2.6M
NIAID NIH HHS R01 AI122720
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by excess B- and T-cell activation, the development of autoantibodies against self-antigens including nuclear antigens, and immune complex deposition in target organs, which triggers an inflammatory response and tissue damage. The genetic and environmental factors that contribute to the development of SLE have been studied extensively in both humans and mouse models of the disease. One of the important genetic contributions to SLE development is an alteration in the expression of the transcription factor Ets1, which regulates the functional differentiation of lymphocytes. Here, we review the genetic, biochemical, and immunological studies that have linked low levels of Ets1 to aberrant lymphocyte differentiation and to the pathogenesis of SLE.

Identifiers

PMID28845756
PMCPMC5695541
OpenAlexW2627538286

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.